By: Mark Fung, The Hockey NewsThe NHL and the NHL Players’ Association are looking into whether a new rule should be in place to make it easier for players to take prescribed muscle relaxant medication.
The league and the union announced Tuesday that they’re looking into the issue of players using a medication called MCT, which was approved by the FDA for the treatment of muscle pain.
The drug can help relieve symptoms of muscle spasms and other muscle injuries.
“We are reviewing the rules, as well as other factors that may have contributed to the prescribing of MCT and will review them in the future,” NHL Deputy Commissioner Bill Daly said.MCT is a non-addictive, non-steroidal anti-inflammatory drug that is approved for the use of the shoulder and hip muscles.
The FDA approved the drug in 2011 for treating pain and inflammation associated with chronic inflammation.
But it was not approved for use in treating pain associated with injuries.
The new rule would apply to the use and prescription of Mct in sports, including hockey, where it’s already legal.
“It would be a mistake to make that assumption, particularly given the fact that it is an opioid medication and not a muscle relaxer,” Daly said in a news release.
The NHL is asking the NHLPA to work with the league to find a way to allow players to get the drug while on the ice, as opposed to taking it after games or after the game, when it’s a prescribed medication.
“Players who are on medication for chronic pain and who are participating in sports are often prescribed a different kind of medication than non-players,” Daly added.
“If there are any questions that we may need to ask, that will be discussed with the players and they will be able to respond.”
A player who has used MCT before would still need to get a prescription from a doctor to get off the drug, Daly said, but if a player took the drug after a game, they would not need to receive a prescription.